Setmelanotide (or RM-493) is an agonist of the appetite-regulating melanocortin-4 receptor which is being investigated for different forms of genetic obesity, including Bardet-Biedl syndrome. The gene discussed is MC4R; the disease is Bardet-Biedl syndrome.